Centrality of the Childhood Cancer Experience and Its Relation to Post-traumatic Stress and Growth
Overview
Psychology
Affiliations
Objective: Event centrality, the degree to which a traumatic event is perceived as central to one's identity, has been associated with post-traumatic stress (PTS) symptoms and post-traumatic growth (PTG) outcomes in various trauma samples. Trauma frameworks are widely used to understand the psychological impact of pediatric cancer; however, event centrality has not been studied in this population. We investigated event centrality in pediatric cancer survivors and healthy comparisons, and its relation with PTS and PTG outcomes.
Method: Cancer survivors, age 13-23 (N = 196) and healthy comparisons (N = 131) completed the Centrality of Events Scale and PTS and PTG measures in reference to their most traumatic life event. Cancer survivors who first identified a non-cancer-related event repeated all measures in reference to cancer.
Results: Centrality scores were significantly higher when referencing cancer compared to non-cancer events, even in survivors for whom cancer was not rated as most stressful (53.1%). Centrality scores for non-cancer events were not significantly different between survivors and healthy comparisons. Event centrality showed significant positive relations to both PTS and PTG outcomes.
Conclusion: The pediatric cancer experience is perceived as central to survivors' identity regardless of whether the experience is perceived as highly traumatic. Centrality of cancer is a significant predictor of both positive and negative psychological outcomes in cancer survivors.
Guido A, Marconi E, Peruzzi L, Dinapoli N, Tamburrini G, Attina G Cancers (Basel). 2024; 16(5).
PMID: 38473253 PMC: 10931029. DOI: 10.3390/cancers16050891.
Ionio C, Bigoni F, Sacchi M, Zecca M, Bergami E, Landoni M Pediatr Rep. 2023; 15(1):254-262.
PMID: 36976728 PMC: 10056441. DOI: 10.3390/pediatric15010021.
Posttraumatic growth in children aged 8-18 years with malignancies in China.
Liu Y, Liu Q, Yu L, Mo L BMC Pediatr. 2022; 22(1):742.
PMID: 36581859 PMC: 9798681. DOI: 10.1186/s12887-022-03799-w.
Ma J, Qian H, Peng Y, Xiang Y, Yang M, Hahne J BMJ Open. 2022; 12(9):e060629.
PMID: 36137628 PMC: 9511543. DOI: 10.1136/bmjopen-2021-060629.
Werk R, Koyama T, Sun L, Wolden S, Kelly K, Constine L J Adolesc Young Adult Oncol. 2022; 12(3):359-365.
PMID: 36094417 PMC: 10282797. DOI: 10.1089/jayao.2022.0053.